Search results
Results from the WOW.Com Content Network
Coronavirus disease 2019 (COVID-19, also known as SARS-2) is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic. The symptoms of COVID‑19 can vary but often include fever, [7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.
Suspect case: "a patient with acute respiratory illness (fever and at least one sign/symptom of respiratory disease, e.g. cough, shortness of breath), and a history of travel to or residence in a location reporting community transmission of COVID-19 disease during the 14 days prior to symptom onset" OR" a patient with any acute respiratory ...
The WHO warned of a potential "second wave" of COVID-19 infections in an update to its strategic advice to governments, as some European countries began to relax lockdown measures. [70] On 19 April, the Director-General of the WHO urged the G20 leading global economies to plan to ease lockdowns against COVID-19 only as part of "a phased process ...
The principal for obstetric management of COVID-19 include rapid detection, isolation, and testing, profound preventive measures, regular monitoring of fetus as well as of uterine contractions, peculiar case-to-case delivery planning based on severity of symptoms, and appropriate post-natal measures for preventing infection.
COVID-19 symptoms range from asymptomatic to deadly, but most commonly include fever, sore throat, nocturnal cough, and fatigue. Transmission of the virus is often through airborne particles. Mutations have produced many strains (variants) with varying degrees of infectivity and virulence. [9]
The earliest reports of a coronavirus infection in animals occurred in the late 1920s, when an acute respiratory infection of domesticated chickens emerged in North America. [15] Arthur Schalk and M.C. Hawn in 1931 made the first detailed report which described a new respiratory infection of chickens in North Dakota .
In a study examining COVID-19 infections, hospitalizations, and deaths in Nebraska after vaccination with the 2023-2024 vaccines that targeted the XBB.1.5 variant, researchers found that vaccine ...
Masitinib was found to inhibit SARS-CoV-2 main protease, showing a greater than 200-fold reduction in viral titers in the lungs and nose of mice, however it is not approved for the treatment of COVID-19 in humans.